Skip to main content
. Author manuscript; available in PMC: 2013 Dec 10.
Published in final edited form as: Cancer. 2008 Jun 15;112(12):10.1002/cncr.23491. doi: 10.1002/cncr.23491

TABLE 2.

Patient Characteristics, TS mRNA Expression, and Survival

Patient characteristics
TS by RT-PCR
No. (92) Median overall survival, mo Log-rank P Median No. (85) Kruskal-Wallis P
Stage
 IA 39 NR .671 3.42 37 .642
 IB 53 74.9 3.65 48
Histology
 Adeno 41 62.2 .642 2.25 39 .002
 BAC 7 87.4 0.50 6
 Squamous 33 NR 4.73 30
 Large cell 11 69.4 5.08 10
Performance status
 0 52 80.4 .771 3.47 52 .853
 1–2 33 62.1 3.87 26
Weight loss, >5% in 3 mo
 Absent 75 80.4 .020 3.52 69 .703
 Present 6 34.1 5.60 6
Smoking status
 Never 6 31.2 .898 4.53 4 .057
 Quit 55 74.9 2.26 51
 Active 27 88.2 5.16 26
Sex
 Women 39 88.2 .605 4.04 35 .652
 Men 53 74.9 2.33 50

TS indicates thymidylate synthase; RT-PCR, reverse-transcriptase polymerase chain reaction; NR, not reached.